temoporfin has been researched along with Prostatic Neoplasms in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aubertin, K; Boggetto, N; Bonneau, S; Bureau, MF; Clément, O; Gazeau, F; Kolosnjaj-Tabi, J; Luciani, N; Marangon, I; Silva, AK; Wilhelm, C | 1 |
| Sehgal, I; Sibrian-Vazquez, M; Vicente, MG | 1 |
| Emberton, M; Moore, CM; Pendse, D | 1 |
| Andersson-Engels, S; Axelsson, J; Swartling, J | 1 |
| Ahmed, HU; Arumainayagam, N; Emberton, M; Moore, CM | 1 |
| Graefe, S; Gyenge, EB; Hiestand, S; Maake, C; Walt, H | 1 |
| Alexandratou, E; Kyriazi, M; Petri, A; Rallis, M; Roussis, V; Yova, D | 1 |
| Alexandratou, E; Kyriazi, M; Petri, A; Rallis, M; Yova, D | 1 |
| Bown, SG; Chang, SC; Emberton, M; Gillams, AR; Jones, L; Lees, WR; Mundy, AR; Nathan, TR; Parkinson, MC; Payne, H; Ripley, PM; Whitelaw, DE | 1 |
| Baas, P; Haller, U; Klein, SD; Walt, H; Zimmermann, A | 1 |
| Bown, SG; Emberton, M; Freeman, A; Lees, WR; Moore, CM; Mosse, CA; Nathan, TR | 1 |
| Bown, SG; Buonaccorsi, G; Chang, SC; MacRobert, A | 1 |
| Chang, SC; Chern, IF; Hsu, YH | 1 |
2 review(s) available for temoporfin and Prostatic Neoplasms
| Article | Year |
|---|---|
Photodynamic therapy for prostate cancer--a review of current status and future promise.
Topics: Bacteriochlorophylls; Forecasting; Humans; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms | 2009 |
Photodynamic therapy for focal ablation of the prostate.
Topics: Dihematoporphyrin Ether; Humans; Male; Mesoporphyrins; Metalloporphyrins; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Treatment Outcome | 2010 |
2 trial(s) available for temoporfin and Prostatic Neoplasms
| Article | Year |
|---|---|
Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study.
Topics: Adenocarcinoma; Aged; Biopsy; Follow-Up Studies; Humans; Male; Mesoporphyrins; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Prostate; Prostatic Neoplasms; Retreatment; Treatment Failure | 2002 |
Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
Topics: Aged; Biopsy; Fibrosis; Humans; Magnetic Resonance Imaging; Male; Mesoporphyrins; Middle Aged; Necrosis; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Treatment Outcome | 2006 |
9 other study(ies) available for temoporfin and Prostatic Neoplasms
| Article | Year |
|---|---|
Magnetic and photoresponsive theranosomes: translating cell-released vesicles into smart nanovectors for cancer therapy.
Topics: Animals; Cell Membrane; Drug Carriers; Female; Humans; Hydrophobic and Hydrophilic Interactions; Magnetic Resonance Imaging; Magnets; Male; Mesoporphyrins; Mice; Nanostructures; Photosensitizing Agents; Prostatic Neoplasms; Uterine Cervical Neoplasms | 2013 |
Photoinduced cytotoxicity and biodistribution of prostate cancer cell-targeted porphyrins.
Topics: Animals; Cell Survival; Dihematoporphyrin Ether; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Light; Lysosomes; Male; Mesoporphyrins; Mice; Mice, SCID; Molecular Structure; Peptides; Photochemistry; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prostatic Neoplasms; Stereoisomerism; Time Factors; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2008 |
In vivo photosensitizer tomography inside the human prostate.
Topics: Antineoplastic Agents; Contrast Media; Humans; Image Interpretation, Computer-Assisted; Male; Mesoporphyrins; Microscopy, Fluorescence; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; Tomography | 2009 |
Cellular and molecular effects of the liposomal mTHPC derivative Foslipos in prostate carcinoma cells in vitro.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; DNA Repair; DNA, Neoplasm; Gene Expression; Humans; Liposomes; Male; Mesoporphyrins; Oxidative Stress; Photochemotherapy; Photosensitizing Agents; Prostatic Neoplasms; RNA, Neoplasm | 2011 |
Combination of Fospeg-IPDT and a natural antioxidant compound prevents photosensitivity in a murine prostate cancer tumour model.
Topics: Animals; Antioxidants; Biological Products; Cell Line, Tumor; Drug Carriers; Humans; Male; Mesoporphyrins; Mice; Mice, SCID; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Pinus; Plant Extracts; Polyethylene Glycols; Prostatic Neoplasms; Treatment Outcome | 2012 |
Comparative characterization of the cellular uptake and photodynamic efficiency of Foscan® and Fospeg in a human prostate cancer cell line.
Topics: Cell Line, Tumor; Cell Survival; Humans; Liposomes; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Prostatic Neoplasms | 2012 |
Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient.
Topics: Apoptosis; Breast Neoplasms; Carcinoma, Basal Cell; Floxuridine; Fluorouracil; Humans; Male; Mesoporphyrins; Photochemotherapy; Photosensitizing Agents; Porphyrins; Prostatic Neoplasms; Skin Neoplasms; Tumor Cells, Cultured | 2003 |
Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin.
Topics: Animals; Antineoplastic Agents; Dogs; Male; Mesoporphyrins; Necrosis; Photochemotherapy; Prostate; Prostatic Neoplasms; Radiation-Sensitizing Agents; Spectrometry, Fluorescence; Tissue Distribution; Ultrasonography; Urethra | 1996 |
Biological responses of dog prostate and adjacent structures after meso-tetra-(m-hydroxyphenyl) chlorin and aluminum disulfonated phthalocyanine based photodynamic therapy.
Topics: Animals; Dogs; Epithelium; Indoles; Male; Mesoporphyrins; Organometallic Compounds; Photochemotherapy; Photosensitizing Agents; Prostate; Prostatic Neoplasms; Rectal Diseases; Skin; Urethral Diseases; Urination Disorders | 1999 |